Balchem Corporation develops, manufactures, and markets specialty ingredients and performance products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. The company is headquartered in New Hampton, New York.
| Revenue (TTM) | $1.04B |
| Gross Profit (TTM) | $370.63M |
| EBITDA | $254.73M |
| Operating Margin | 19.80% |
| Return on Equity | 12.90% |
| Return on Assets | 8.02% |
| Revenue/Share (TTM) | $32.15 |
| Book Value | $39.22 |
| Price-to-Book | 4.34 |
| Price-to-Sales (TTM) | 5.30 |
| EV/Revenue | 5.36 |
| EV/EBITDA | 21.83 |
| Quarterly Earnings Growth (YoY) | 17.30% |
| Quarterly Revenue Growth (YoY) | 9.80% |
| Shares Outstanding | $32.03M |
| Float | $31.81M |
| % Insiders | 0.42% |
| % Institutions | 92.01% |